Prevalence of hyperphosphatemiaExcretionChronic KidneyDiagnosis of hyperphosphatemiaHypercalcemiaUrinary phosphateAbnormally highPathophysiologyDialysisParathyroid hormonePatientsSpuriousTenapanorToxicitySecondaryElectrolyteCalcificationDrugs MarketPhosphate administrationTreatmentSevereSodiumClinicalDoseOccasionallyLevelsCondition
Prevalence of hyperphosphatemia3
- The aging population can be considered as the most crucial reason for the rising prevalence of hyperphosphatemia disorders that is driving the growth of the Spain market. (researchandmarkets.com)
- Elderly individuals are more susceptible to kidney-related conditions, leading to a higher prevalence of hyperphosphatemia in this demographic. (imarcgroup.com)
- When examined collectively, the population attributable risk percentage for disorders of mineral metabolism was 17.5%, owing largely to the high prevalence of hyperphosphatemia. (nih.gov)
Excretion4
- Hyperphosphatemia-that is, abnormally high serum phosphate levels-can result from increased phosphate intake, decreased phosphate excretion, or a disorder that shifts intracellular phosphate to extracellular space. (medscape.com)
- In cases of chronic kidney diseases and elderly people, the loss of phosphorus homeostasis due to phosphorus excretion failure causes hyperphosphatemia. (researchandmarkets.com)
- In renal insufficiency , phosphorus excretion declines and hyperphosphatemia develops. (bvsalud.org)
- A woman has hypocalcemia, hyperphosphatemia, and decreased urinary phosphate excretion. (proprofs.com)
Chronic Kidney4
- Abnormalities in phosphate metabolism such as hyperphosphatemia are included in the definition of the new chronic kidney disease-mineral and bone disorder (CKD-MBD). (wikipedia.org)
- Hyperphosphatemia is extremely common in people with Chronic Kidney Disease , and it occurs even more frequently in people with end-stage kidney disease. (reportsanddata.com)
- Hyperphosphatemia is a common complication in dialysis-dependent patients with chronic kidney disease. (amsterdamumc.org)
- [ 2 ] Although chronic kidney disease (CKD) often leads to hyperphosphatemia, abnormalities in phosphorus levels have been observed in populations with and without kidney disease. (medscape.com)
Diagnosis of hyperphosphatemia2
- The diagnosis of hyperphosphatemia is made through measuring the concentration of phosphate in the blood. (wikipedia.org)
- Furthermore, the increasing awareness and diagnosis of hyperphosphatemia in patients with CKD and ESRD have also contributed to market expansion. (imarcgroup.com)
Hypercalcemia1
- Disorders of mineral metabolism (hyperphosphatemia, hypercalcemia, and secondary hyperparathyroidism) are potentially modifiable. (nih.gov)
Urinary phosphate1
- Rarely, if the cause of hyperphosphatemia is not clear, 24-hour measurement of urinary phosphate can be performed. (medscape.com)
Abnormally high1
- Hyperphosphatemia drugs are medications used to treat a medical condition called hyperphosphatemia, characterized by abnormally high levels of phosphate in the blood. (imarcgroup.com)
Pathophysiology1
- The pathophysiology of hyperphosphatemia associated with end-stage renal disease and treatment with phosphate binders are discussed. (bvsalud.org)
Dialysis6
- Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders. (medscape.com)
- Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients. (medscape.com)
- The use of various phosphate-binders in dialysis patients has prompted several studies in the U.S., driving revenue growth of the North America hyperphosphatemia treatment market. (reportsanddata.com)
- Calcium acetate is used to treat hyperphosphatemia (too much phosphate in the blood) in patients with end stage kidney disease who are on dialysis. (drugs.com)
- The treatment of hyperphosphatemia in patients with chronic renal failure includes dialysis , dietary phosphorus restrictions, phosphate -binding medications, and vitamin D analogs. (bvsalud.org)
- [ 5 ] In dialysis and kidney transplant patients, hyperphosphatemia is associated with anemia independent of other mineral bone disease components. (medscape.com)
Parathyroid hormone1
- Hyperphosphatemia can also be caused by Diabetic Ketoacidosis , uncontrolled diabetes, high Vitamin D levels, and low parathyroid hormone levels. (reportsanddata.com)
Patients6
- Although most patients with hyperphosphatemia are asymptomatic, they occasionally report hypocalcemic symptoms, such as muscle cramps, tetany, and perioral numbness or tingling. (medscape.com)
- More commonly, patients report symptoms related to the underlying cause of the hyperphosphatemia. (medscape.com)
- While its aim with hyperphosphatemia patients was to stop phosphorus absorption, in people with IBS-C, it inhibits dietary sodium uptake. (healthline.com)
- Elevated water secretion likely played a role in why hyperphosphatemia patients without constipation experienced diarrhea while taking this medication. (healthline.com)
- Les patients étaient inclus en accord avec les critères de consensus internationaux. (bvsalud.org)
- Elle a mis en exergue l'intérêt de la réorganisation de la prise en charge de ces patients en période de crise sanitaire, l'éducation thérapeutique des patients et le recours à la télémédecine pour assurer la continuité des soins. (bvsalud.org)
Spurious1
- Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter. (medscape.com)
Tenapanor3
- Ardelik, Inc. ARDX announced that the FDA granted orphan designation to Xphozah (tenapanor) for the treatment of hyperphosphatemia in children. (booblogs.com)
- Ardelyx, the manufacturer of tenapanor, switched gears to target hyperphosphatemia, a condition that causes extra phosphorus in the blood, instead of IBS-C. (healthline.com)
- After an FDA review in July 2021 of tenapanor to treat hyperphosphatemia, the medication was pivoted again and launched in April 2022 as the first and only NHE3 inhibitor for the treatment of IBS-C. (healthline.com)
Toxicity1
- [ 13-15 ] In murine models that lack FGF-23 or klotho, the resultant hyperphosphatemia is associated with cell toxicity, premature aging and vascular calcifications. (medscape.com)
Secondary1
- If left untreated, hyperphosphatemia can result in secondary hyperparathyroidism , renal osteodystrophy , and metastatic calcification of blood vessels and soft tissue . (bvsalud.org)
Electrolyte1
- Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. (wikipedia.org)
Calcification1
- In the CKD clients, conditions within the bones remodeling can lead to extreme launch of phosphorus and calcium supplements on the blood, and this exacerbates hyperphosphatemia and vascular calcification and you can accelerates the fresh decline off kidney function. (kaamcha.com)
Drugs Market5
- The increasing aging population in Spain is considered as the major driving factor to strengthen the demand of the hyperphosphatemia drugs market in the country. (researchandmarkets.com)
- And this is growing the demand for the hyperphosphatemia drugs market in the country. (researchandmarkets.com)
- Moreover, the growing aging population is contributing to the expansion of the hyperphosphatemia drugs market. (imarcgroup.com)
- The global prevalence of Chronic Kidney Diseases (CKD) is expected to drive the hyperphosphatemia drugs market revenue growth. (reportsanddata.com)
- Strategic mergers and acquisitions by key market players are also expected to create a profitable environment for revenue growth of the hyperphosphatemia drugs market. (reportsanddata.com)
Phosphate administration1
- Hyperphosphatemia can also occur with excessive oral phosphate administration and occasionally with overzealous use of enemas containing phosphate. (msdmanuals.com)
Treatment5
- Sidley represented Alebund Pharmaceuticals (Alebund) in its option and license agreement with Chugai Pharmaceutical Co., Ltd. (Chugai) in relation to EOS789, an oral inhibitor of phosphate transporters under development for the treatment of hyperphosphatemia. (sidley.com)
- The hyperphosphatemia treatment market is expected to register a steady revenue CAGR during the forecast period. (reportsanddata.com)
- Increasing number of drug launches in developing economies is expected to drive hyperphosphatemia treatment market growth. (reportsanddata.com)
- In the hyperphosphatemia treatment market, there appears to be an unmet need for developing calcium acetate/magnesium combination products. (reportsanddata.com)
- North America has emerged as a potentially profitable region in the global hyperphosphatemia treatment market, with healthcare providers increasingly focusing on implementing the Kidney Disease Improving Global Outcomes (KDIGO) guidelines. (reportsanddata.com)
Severe1
- However, even severe hyperphosphatemia is for the most part clinically asymptomatic. (medscape.com)
Sodium1
- citation needed] Drugs: hyperphosphatemia can also be caused by taking oral sodium phosphate solutions prescribed for bowel preparation for colonoscopy in children. (wikipedia.org)
Clinical1
- This article reviews the key results from these observational studies of sucroferric oxyhydroxide and evaluates its role in the management of hyperphosphatemia in clinical practice. (amsterdamumc.org)
Dose1
- Monitor for hyperphosphatemia and manage with dose modifications when required. (nih.gov)
Occasionally1
- Hyperphosphatemia occasionally results from a transcellular shift of phosphate into the extracellular space that is so large that the renal excretory capacity is overwhelmed. (msdmanuals.com)
Levels1
- Hyperphosphatemia: Increases in phosphate levels are a pharmacodynamic effect of BALVERSA. (nih.gov)
Condition2
- Hyperphosphatemia is a condition caused by a high phosphate or phosphorous level in the blood. (reportsanddata.com)
- Hyperphosphatemia is a medical condition involving too much phosphate in the blood. (medicalnewstoday.com)